Keywords: myriad, starts, ph, study, cancer, drug, genetics

Myriad starts Ph I study of cancer drug

Article | 07 March 2005

Print This

Myriad Genetics of the USA says it has initiated a second Phase I clinical trial of its cancer agent MPC-6827 ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in